Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 7
1948 1
1949 2
1950 2
1952 2
1953 4
1954 1
1955 2
1956 2
1957 1
1958 3
1959 2
1960 2
1961 5
1962 2
1963 2
1964 4
1965 2
1966 1
1967 2
1968 4
1969 3
1971 1
1972 2
1973 1
1974 1
1975 2
1976 1
1977 2
1978 2
1979 1
1982 3
1983 5
1984 2
1985 3
1986 4
1987 10
1988 13
1989 12
1990 10
1991 19
1992 13
1993 12
1994 9
1995 12
1996 14
1997 16
1998 9
1999 14
2000 18
2001 25
2002 33
2003 44
2004 33
2005 53
2006 49
2007 48
2008 52
2009 56
2010 50
2011 46
2012 43
2013 43
2014 61
2015 87
2016 94
2017 88
2018 80
2019 65
2020 63
Text availability
Article attribute
Article type
Publication date

Search Results

1,257 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Glowicka-Woloszyn
Page 1
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC. Temel JS, et al. Lancet Oncol. 2016 Apr;17(4):519-531. doi: 10.1016/S1470-2045(15)00558-6. Epub 2016 Feb 20. Lancet Oncol. 2016. PMID: 26906526 Clinical Trial.
METHODS: ROMANA 1 and ROMANA 2 were randomised, double-blind, placebo-controlled phase 3 trials done at 93 sites in 19 countries. ...We noted no difference in handgrip strength in ROMANA 1 (-1·10 kg [-1·69 to -0·40] vs -1·58 kg [-2·99 to -1·14], p=0·15) or …
METHODS: ROMANA 1 and ROMANA 2 were randomised, double-blind, placebo-controlled phase 3 trials done at 93 sites in 19 countri …
ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC. Currow D, et al. Ann Oncol. 2017 Aug 1;28(8):1949-1956. doi: 10.1093/annonc/mdx192. Ann Oncol. 2017. PMID: 28472437 Free PMC article. Clinical Trial.
RESULTS: Of the 703 patients who completed ROMANA 1 and ROMANA 2, 513 patients entered ROMANA 3 (anamorelin, N = 345, mean age 62.0 years; placebo, N = 168; mean age 62.2 years). ...CLINICAL TRIAL REGISTRATION NUMBERS: ROMANA 1 (NCT01387269), ROMANA
RESULTS: Of the 703 patients who completed ROMANA 1 and ROMANA 2, 513 patients entered ROMANA 3 (anamorelin, N = 345, m …
Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS, Chela H, Dailey FE, Nassir F, Tahan V. Romana BS, et al. Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. doi: 10.2174/1871530318666180328111302. Endocr Metab Immune Disord Drug Targets. 2018. PMID: 29595117 Review.
Impact of Gravity on Thyroid Cells.
Albi E, Krüger M, Hemmersbach R, Lazzarini A, Cataldi S, Codini M, Beccari T, Ambesi-Impiombato FS, Curcio F. Albi E, et al. Int J Mol Sci. 2017 May 4;18(5):972. doi: 10.3390/ijms18050972. Int J Mol Sci. 2017. PMID: 28471415 Free PMC article. Review.
Microparticles in sickle cell disease.
Romana M, Connes P, Key NS. Romana M, et al. Clin Hemorheol Microcirc. 2018;68(2-3):319-329. doi: 10.3233/CH-189014. Clin Hemorheol Microcirc. 2018. PMID: 29614639 Free article.
Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.
Fuior EV, Gafencu AV. Fuior EV, et al. Int J Mol Sci. 2019 Nov 26;20(23):5939. doi: 10.3390/ijms20235939. Int J Mol Sci. 2019. PMID: 31779116 Free PMC article. Review.
Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
Currow DC, Maddocks M, Cella D, Muscaritoli M. Currow DC, et al. Int J Mol Sci. 2018 Nov 5;19(11):3471. doi: 10.3390/ijms19113471. Int J Mol Sci. 2018. PMID: 30400622 Free PMC article. Review.
In the ROMANA studies, compared with placebo, anamorelin significantly increased lean body mass in non-small cell lung cancer (NSCLC) patients. ...The ROMANA trials have provided unprecedented knowledge, highlighting the therapeutic effects of anamorelin as an initi …
In the ROMANA studies, compared with placebo, anamorelin significantly increased lean body mass in non-small cell lung cancer (NSCLC) …
ADHD symptoms induced by prenatal methamphetamine exposure.
Ochozková A, Mihalčíková L, Yamamotová A, Šlamberová R. Ochozková A, et al. Physiol Res. 2019 Dec 20;68(Suppl 3):S347-S352. doi: 10.33549/physiolres.934358. Physiol Res. 2019. PMID: 31928052 Free article.
A Comparative Study on Essential Oil Intraspecific and Seasonal Variations: Melissa romana Mill. and Melissa officinalis L. from Sardinia.
Usai M, Atzei AD, Marchetti M. Usai M, et al. Chem Biodivers. 2016 Aug;13(8):1076-87. doi: 10.1002/cbdv.201500507. Epub 2016 Aug 17. Chem Biodivers. 2016. PMID: 27449960
In this paper, we present the results of the research about morphological aspects of M. romana vs. M. officinalis, and their essential oils in different stations at different phenological periods. Moreover, we compared the essential oil of M. romana with the one obt …
In this paper, we present the results of the research about morphological aspects of M. romana vs. M. officinalis, and their essentia …
Authentication of an Italian PDO hazelnut ("Nocciola Romana") by NIR spectroscopy.
Biancolillo A, De Luca S, Bassi S, Roudier L, Bucci R, Magrì AD, Marini F. Biancolillo A, et al. Environ Sci Pollut Res Int. 2018 Oct;25(29):28780-28786. doi: 10.1007/s11356-018-1755-2. Epub 2018 Mar 21. Environ Sci Pollut Res Int. 2018. PMID: 29564708
In the light of this, the present work aims to develop a non-destructive method for the authentication of a specific high-quality Italian hazelnut, "Nocciola Romana," registered with a protected designation of origin (PDO). ...
In the light of this, the present work aims to develop a non-destructive method for the authentication of a specific high-quality Italian ha …
1,257 results
Jump to page
Feedback